Protected: Build Your Culture with the Right People – Dan Recommends
There is no excerpt because this is a protected post.
Protected: Roundtable Q&A with V2V’s Technology Innovation Team
There is no excerpt because this is a protected post.
Protected: V2V Wins 2024 Better Business Bureau Torch Award for Ethics and Excellence
There is no excerpt because this is a protected post.
Vision2Voice Recieves the 2014 BBB Integrity Award
OMAHA, NE – October 7, 2014 – Vision2Voice was awarded the 2014 Better Business Bureau Integrity Award in Omaha, NE at the Embassy Suites in Omaha –La Vista Conference Center on Tuesday, October 7, 2014. These awards focus on demonstrated ethical business practices with key stakeholders including customers, employees, and
Protected: Conquering the Whirlwind
There is no excerpt because this is a protected post.
The Future of Big Pharma: Preventative Medicine?
Rising healthcare costs in the United States have caused government, corporate, and association leaders to look for ways to make our healthcare system more efficient. Insurance provider and Affordable Care Act plans both provide for preventative care in order to keep long term costs down for the patient and the
Wait, the Doctor-Patient Conversation?
In pharma marketing, messaging and targeting are everything. The most appropriate words delivered to a carefully selected group of healthcare professionals leads to patients getting the best treatments. Or does it? When listening to patients and physicians separately, we often get different answers. Asking a patient how a diagnosis was delivered
Simplifying Oncology: Incorporate KOLS
The last decade has brought a variety of innovative cancer treatment options to the market. A 2009 study conducted by PhRMA compiled a list of 129 medications in development to treat Leukemia, 122 to treat lung cancer, and 106 to treat breast cancer[1]. The number of oncology patients has steadily grown
